Cord blood chemerin: differential effects of gestational diabetes mellitus and maternal obesity. (5th April 2013)
- Record Type:
- Journal Article
- Title:
- Cord blood chemerin: differential effects of gestational diabetes mellitus and maternal obesity. (5th April 2013)
- Main Title:
- Cord blood chemerin: differential effects of gestational diabetes mellitus and maternal obesity
- Authors:
- van, Mireille N. M.
Zeck, Willibald
Ulrich, Daniela
Schest, Eva‐Christina
Hirschmugl, Birgit
Lang, Uwe
Wadsack, Christian
Desoye, Gernot - Abstract:
- <abstract abstract-type="main" xml:lang="en" id="cen12140-abs-0001"> <title>Summary</title> <sec id="cen12140-sec-0001" sec-type="section"> <title>Objective</title> <p>Chemerin is a novel adipokine implicated in inflammation and obesity. We hypothesized that foetal chemerin would be elevated in gestational diabetes mellitus (GDM) and correlate with foetal and maternal adiposity.</p> </sec> <sec id="cen12140-sec-0002" sec-type="section"> <title>Design</title> <p>Observational, longitudinal study.</p> </sec> <sec id="cen12140-sec-0003" sec-type="section"> <title>Subjects and measurements</title> <p>Foetal chemerin was measured separately in arterial and venous cord blood of 30 infants born to mothers with (<italic>n</italic> = 15) and without GDM (<italic>n</italic> = 15), in their mothers in early third trimester and at delivery and in amniotic fluid (week 32) of women with GDM. Expression of chemerin and its receptor in human foetal tissues commercially available and in placental cells was measured by quantitative PCR. Associations between foetal and maternal anthropometric and metabolic variables were assessed in multivariate regression models.</p> </sec> <sec id="cen12140-sec-0004" sec-type="section"> <title>Results</title> <p>In GDM, foetal arterial but not venous cord blood chemerin levels were elevated by about 60% (<italic>P</italic> &lt; 0·05). Venous cord blood chemerin was higher in infants of obese women (<italic>P</italic> &lt; 0·01). In multivariate analyses,<abstract abstract-type="main" xml:lang="en" id="cen12140-abs-0001"> <title>Summary</title> <sec id="cen12140-sec-0001" sec-type="section"> <title>Objective</title> <p>Chemerin is a novel adipokine implicated in inflammation and obesity. We hypothesized that foetal chemerin would be elevated in gestational diabetes mellitus (GDM) and correlate with foetal and maternal adiposity.</p> </sec> <sec id="cen12140-sec-0002" sec-type="section"> <title>Design</title> <p>Observational, longitudinal study.</p> </sec> <sec id="cen12140-sec-0003" sec-type="section"> <title>Subjects and measurements</title> <p>Foetal chemerin was measured separately in arterial and venous cord blood of 30 infants born to mothers with (<italic>n</italic> = 15) and without GDM (<italic>n</italic> = 15), in their mothers in early third trimester and at delivery and in amniotic fluid (week 32) of women with GDM. Expression of chemerin and its receptor in human foetal tissues commercially available and in placental cells was measured by quantitative PCR. Associations between foetal and maternal anthropometric and metabolic variables were assessed in multivariate regression models.</p> </sec> <sec id="cen12140-sec-0004" sec-type="section"> <title>Results</title> <p>In GDM, foetal arterial but not venous cord blood chemerin levels were elevated by about 60% (<italic>P</italic> &lt; 0·05). Venous cord blood chemerin was higher in infants of obese women (<italic>P</italic> &lt; 0·01). In multivariate analyses, neither amniotic fluid nor cord blood chemerin levels correlated with birth weight or ponderal index. Both arterial and venous chemerin levels were related to maternal chemerin at birth, and arterial chemerin was associated with GDM status in addition. Maternal levels were unaltered in GDM, but higher in maternal obesity. Foetal liver produces fourfold more chemerin mRNA than other foetal tissues, whereas its receptor prevails in spleen.</p> </sec> <sec id="cen12140-sec-0005" sec-type="section"> <title>Conclusions</title> <p>Based on multivariate analyses, foetal growth appears unrelated to foetal chemerin. Maternal obesity and GDM have differential effects on foetal chemerin levels. Site of major production (liver) and action (spleen) differ in human foetal tissues.</p> </sec> </abstract> … (more)
- Is Part Of:
- Clinical endocrinology. Volume 80:Number 1(2014:Jan.)
- Journal:
- Clinical endocrinology
- Issue:
- Volume 80:Number 1(2014:Jan.)
- Issue Display:
- Volume 80, Issue 1 (2014)
- Year:
- 2014
- Volume:
- 80
- Issue:
- 1
- Issue Sort Value:
- 2014-0080-0001-0000
- Page Start:
- 65
- Page End:
- 72
- Publication Date:
- 2013-04-05
- Subjects:
- Endocrinology -- Periodicals
616.4005 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2265 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/cen.12140 ↗
- Languages:
- English
- ISSNs:
- 0300-0664
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3286.278000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3424.xml